SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-181509
Filing Date
2006-08-29
Accepted
2006-08-29 16:11:08
Documents
4
Period of Report
2006-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 36267
2 RIGHTS AGREEMENT dex41.htm EX-4.1 270475
3 PRESS RELEASE dex991.htm EX-99.1 5561
4 GRAPHIC g23126img001.jpg GRAPHIC 18929
  Complete submission text file 0001193125-06-181509.txt   340330
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 061062727
SIC: 2836 Biological Products, (No Diagnostic Substances)